The Living Guidelines: Patients with Reduced LVEF. Polling Results for CLASS IIa Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIa Guidelines
1. Angiotensin II receptor blockers are reasonable to use as alternatives to ACEIs as first-line therapy for patients with mild to moderate HF and reduced LVEF, especially for patients already taking ARBs for other indications. (Level of Evidence: A)

 ACC / AHA Guidelines for Diagnosis and Management of Chronic Heart Failure: Class IIa Recommendation 1 for patients with reduced LVEF should be: CLASS I CLASS IIa CLASS IIb CLASS III 2. Digitalis can be beneficial in patients with current or prior symptoms of HF and reduced LVEF to decrease hospitalizations for HF. (Level of Evidence: B)

 ACC / AHA Guidelines for Diagnosis and Management of Chronic Heart Failure: Class IIa Recommendation 2 for patients with reduced LVEF should be: CLASS I CLASS IIa CLASS IIb CLASS III 3. The addition of a combination of hydralazine and a nitrate is reasonable for patients with reduced LVEF who are already taking an ACEI and beta-blocker for symptomatic HF and who have persistent symptoms. (Level of Evidence: A)

 ACC / AHA Guidelines for Diagnosis and Management of Chronic Heart Failure: Class IIa Recommendation 3 for patients with reduced LVEF should be: CLASS I CLASS IIa CLASS IIb CLASS III 4. Placement of an implantable cardioverter-defibrillator is reasonable in patients with LVEF of 30% to 35% of any origin with NYHA functional class II or III symptoms who are taking chronic optimal medical therapy and who have reasonable expectation of survival with good functional status of more than 1 year. (Level of Evidence: B)

 ACC / AHA Guidelines for Diagnosis and Management of Chronic Heart Failure: Class IIa Recommendation 4 for patients with reduced LVEF should be: CLASS I CLASS IIa CLASS IIb CLASS III